Evidence map›Paper›PMID 33837490›Full record

ArticleInternational journal of clinical oncology2021

Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real‑world clinical practice: a multicentre retrospective clinical study.

Nobuhiro Hanai, Yasushi Shimizu, Shin Kariya, Ryuji Yasumatsu, Tomoya Yokota, Takashi Fujii, Kiyoaki Tsukahara, Masafumi Yoshida, Kenji Hanyu, Tsutomu Ueda and 16 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Nobuhiro HanaiDepartment of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
Yasushi ShimizuDepartment of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Shin KariyaDepartment of Otolaryngology, Head and Neck Surgery, Okayama University Hospital, Okayama, Japan.
Ryuji YasumatsuDepartment of Otolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tomoya YokotaDivision of Gastrointestinal Oncology, Shizuoka Cancer Center, Nagaizumi, Japan.
Takashi FujiiDepartment of Head and Neck Surgery, Osaka International Cancer Institute, Osaka, Japan.
Kiyoaki TsukaharaDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Masafumi YoshidaOtorhinolaryngology and Head and Neck Surgery, The University of Tokyo Hospital, Tokyo, Japan.
Kenji HanyuHead and Neck Oncology Center, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.
Tsutomu UedaDepartment of Otorhinolaryngology, Head and Neck Surgery, Hiroshima University Hospital, Hiroshima, Japan.
Hitoshi HirakawaDepartment of Otorhinolaryngology, Head and Neck Surgery, University of the Ryukyu Hospital, Nishihara, Japan.
Shunji TakahashiDepartment of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Takeharu OnoDepartment of Otolaryngology, Head and Neck Surgery, Kurume University Hospital, Kurume, Japan.
Daisuke SanoDepartment of Otolaryngology, Head and Neck Surgery, Yokohama City University Hospital, Yokohama, Japan.
Moriyasu YamauchiDepartment of Otolaryngology, Head and Neck Surgery, Saga University Hospital, Saga, Japan.
Akihito WatanabeDepartment of Otolaryngology, Head and Neck Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Koichi OmoriDepartment of Otolaryngology, Head and Neck Surgery, Kyoto University Hospital, Kyoto, Japan.
Tomoko YamazakiDivision of Head and Neck Cancer Oncology, Miyagi Cancer Center, Sendai, Japan.
Nobuya MondenDepartment of Head and Neck Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Naomi KudoDepartment of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Makoto AraiDepartment of Medical Oncology, Chiba University Hospital, Chiba, Japan.
Daiju SakuraiDepartment of Otorhinolaryngology, Head and Neck Surgery, Chiba University Hospital, Chiba, Japan.
Takahiro AsakageDepartment of Head and Neck Surgery, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan.
Issei DoiMedical Affairs, ONO Pharmaceutical Co., Ltd, Osaka, Japan.
Takayuki YamadaJapan Medical and Development, Bristol-Myers Squibb K.K., Tokyo, Japan.
Akihiro HommaDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita15 Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan. ak-homma@med.hokudai.ac.jp.ORCID http://orcid.org/0000-0003-1488-0646

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33837490
PMCPMC8055618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.